Potential Role of Contact Pathway Factors in Catheter-Related Thrombosis: Emerging Evidence and Therapeutic Strategies
Open Access
- 29 August 2026
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 16 (9) , 1256
Abstract
The catheter is among the most commonly used blood-contacting medical devices, but its use can induce surface-mediated coagulation activation, leading to catheter-related thrombosis (CRT). The occurrence of CRT causes venous thromboembolism and catheter malfunction, but current antithrombotic strategies have unsatisfactory efficacy and safety profiles. Here, we review recent advances in the understanding of the pathology of CRT, particularly the roles of the contact pathway factors, and promising novel therapeutic options. Recent studies using genetically modified animals, factor-deficient plasmas, specific inhibitors and purified systems demonstrated an important contribution of contact pathway factors XII and XI to catheter-related blood clotting. Accordingly, contact pathway inhibition has efficacy comparable to that of heparins in mitigating catheter-related coagulation or intraluminal occlusion in various in vitro and animal models, while having lower bleeding risk. Early human studies suggest potential thromboprotective effects of FXI inhibition in catheter placement and hemodialysis settings. However, inhibition of factors XII or XI may impair the defense against infection or disturb normal cardiac function, respectively. Larger human trials are needed to further confirm the efficacy and safety of these contact pathway inhibitors, and to explore whether low-dose combinations of contact pathway inhibitors with heparins are more effective for CRT protection.Keywords
Funding Information
- National Natural Science Foundation of China (82370137)
- Natural Science Foundation of the Jiangsu Higher Education Institutions (23KJB310021)
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Cyrus Tang Foundation
- Innovation and Entrepreneurship, Soochow University (2025C170)
This publication has 106 references indexed in Scilit:
- Factor XI Inhibitors in Atrial Fibrillation: Insights and Implications from Recent TrialsAdvances in Therapy, 2026
- Rivaroxaban Prophylaxis in Peripherally Inserted Central Catheter-Related Thrombosis in Breast Cancer PatientsArchives of Medical Research, 2025
- Construction and validation of a nomogram prediction model for the catheter-related thrombosis risk of central venous access devices in patients with cancer: a prospective machine learning studyJournal of Thrombosis and Thrombolysis, 2024
- Clinical factors of PICC-RVT in cancer patients: a meta-analysisSupportive Care in Cancer, 2023
- Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19Lung, 2023
- Enoxaparin Reduces Catheter-associated Venous Thrombosis After Infant Cardiac SurgeryThe Annals of Thoracic Surgery, 2021
- Antibody inhibition of contact factor XII reduces platelet deposition in a model of extracorporeal membrane oxygenator perfusion in nonhuman primatesResearch and Practice in Thrombosis and Haemostasis, 2020
- Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trialBritish Journal of Anaesthesia, 2019
- A systematic review of patient-related risk factors for catheter-related thrombosisJournal of Thrombosis and Thrombolysis, 2015
- Factor XII fragment and kallikrein generation in plasma during incubation with biomaterialsJournal of Biomedical Materials Research, 1994